Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries ZyVersa Therapeutics, Inc. - Common Stock (NQ: ZVSA ) 6.180 +1.430 (+30.11%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about ZyVersa Therapeutics, Inc. - Common Stock < Previous 1 2 3 4 5 6 7 Next > ZyVersa Therapeutics' CEO, Stephen C. Glover, Is an Invited Speaker at H.C. Wainwright 3rd Annual Kidney Conference to be Held Virtually on July 15, 2024 July 09, 2024 From ZyVersa Therapeutics Via GlobeNewswire Peering Into ZyVersa Therapeutics's Recent Short Interest May 21, 2024 Via Benzinga ZVSA Stock Earnings: ZyVersa Therapeutics Misses EPS for Q1 2024 May 15, 2024 ZVSA stock results show that ZyVersa Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace ZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update May 15, 2024 From ZyVersa Therapeutics Via GlobeNewswire ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 2024 BIO International Convention May 14, 2024 From ZyVersa Therapeutics Via GlobeNewswire Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 29, 2024 Via Benzinga What's Going On With ZyVersa Stock? April 29, 2024 ZyVersa Therapeutics shares are trading higher Monday after the company announced the publication of a scientific paper in a peer-reviewed journal that reinforces the rationale for inhibiting ASC with... Via Benzinga ZyVersa Therapeutics Announces Publication Reinforcing the Rationale for Inhibiting ASC with IC 100 to Potentially Attenuate Cardiac Comorbidities in Patients with Alzheimer’s Disease April 29, 2024 From ZyVersa Therapeutics Via GlobeNewswire ZyVersa Therapeutics Highlights Published Data Demonstrating NLRP3 Inflammasome Inhibition Has Potential to Decrease Atherosclerotic Lesions in Patients with Diabetes April 04, 2024 From ZyVersa Therapeutics Via GlobeNewswire Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session April 26, 2024 Via Benzinga ZyVersa Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update March 25, 2024 From ZyVersa Therapeutics Via GlobeNewswire Benzinga's 2024 Virtual Healthcare: What's Next In Health? March 19, 2024 The 2024 Benzinga Virtual Healthcare Summit brings together top healthcare professionals and companies to discuss industry trends, advancements in technology, and the future of healthcare. Don't miss... Via Benzinga ZyVersa Therapeutics Announces IRB Approval of Phase 2a Clinical Trial Protocol to Evaluate Cholesterol Efflux Mediator™ VAR 200 in Patients with Diabetic Kidney Disease March 18, 2024 From ZyVersa Therapeutics Via GlobeNewswire ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate in a Panel Discussion Titled “Inflammation Illuminated,”at Benzinga’s Virtual Healthcare Summit 2024 on March 20, 2024 March 14, 2024 From ZyVersa Therapeutics Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session March 07, 2024 Via Benzinga ZyVersa Therapeutics Generated Approximately $2.7 Million From Exercise of Warrants Following Excitement Around News That Inflammasome Inhibitors Have Potential to Effectively Treat Obesity February 29, 2024 From ZyVersa Therapeutics Via GlobeNewswire ZyVersa Therapeutics Highlights Data from Review Article Published in Nature Reinforcing IC 100’s Rationale for Inhibiting ASC and ASC Specks to Attenuate Damaging Inflammation Associated with Various Conditions, Including Obesity and Its Complications February 28, 2024 From ZyVersa Therapeutics Via GlobeNewswire Why TransMedics Group Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket February 27, 2024 Shares of TransMedics Group, Inc. (NASDAQ: TMDX) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong guidance. Via Benzinga Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session February 26, 2024 Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session February 26, 2024 Via Benzinga What In The World Is Going On With ZyVersa Therapeutics (ZVSA) Stock? February 26, 2024 ZyVersa Therapeutics shares are trading higher by 126% Monday. The stock continues to be volatile after the company last week released a white paper. Via Benzinga US Stocks Edge Higher; Domino's Posts Upbeat Earnings February 26, 2024 U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 50 points on Monday. Following the market opening Monday, the Dow traded up 0.04% 39,148.74 while the NASDAQ rose... Via Benzinga Topics Stocks Exposures US Equities Why Is Intuitive Machines (LUNR) Stock Down 23% Today? February 26, 2024 Intuitive Machines stock is falling on Monday as investors in LUNR react to an update on the company's lunar landing last week. Via InvestorPlace Why Is Aclarion (ACON) Stock Down 19% Today? February 26, 2024 Aclarion stock is falling on Monday as investors react to news of a public offering for shares of ACON and a delisting update. Via InvestorPlace Why Is Freight Technologies (FRGT) Stock Up 25% Today? February 26, 2024 Freight Technologies stock is heading higher on Monday with heavy trading of FRGT alongside a collaboration deal with Envases Universales. Via InvestorPlace Why Intuitive Machines Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket February 26, 2024 Shares of Intuitive Machines, Inc. (NASDAQ: LUNR) fell sharply in today’s pre-market trading. Intuitive Machines revealed Friday that its lunar lander, Odysseus, encountered a mishap during a touchdown... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session February 26, 2024 Via Benzinga Why Is ZyVersa Therapeutics (ZVSA) Stock Up 37% Today? February 26, 2024 ZyVersa Therapeutics stock is rising higher on Monday as shares of ZVDA experience heavy pre-market trading this morning. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday February 26, 2024 We're starting the trading week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning! Via InvestorPlace 12 Health Care Stocks Moving In Friday's After-Market Session February 23, 2024 Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.